APLSUSD Institutional Ownership
APELLIS PHARMACEUTICALS INC
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred
from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
Free access includes current parsed ownership filings, reported share changes, and ownership-percentage changes.
Filing-specific significance scoring, disclosure-speed analysis, confirmation/divergence signals, and signal alerts require Investor or Pro. The overall institutional consensus preview remains public.
Compare plans.
Cross-institution intelligence
Institutional Research
Each institution is compared with its own prior filing, then the latest institution-level directions are compared for breadth.
Latest filing
May 12, 2026
Public consensus preview
Mixed positioning
50/100 institutional research score
3 tracked institutions
Latest filing May 12, 2026
No institution has two comparable Schedule 13 observations yet.
Accumulating0
Unchanged0
Reducing0
Exited0
The overall consensus is public. Detailed holder comparisons, breadth history, ownership charts, and filing-specific signal analysis remain part of Investor and Pro research.
Price context
52-week position is market context and does not change the institutional consensus score.
52-week range data is not available for this security yet.
Tracked institutions
Public holder names and filing freshness. Detailed institution-by-institution analysis is locked.
Morgan Stanley
Jun 5, 2026 filed
State Street
May 12, 2026 filed
T. Rowe Price Investment Management
Nov 14, 2024 filed
BlackRock Legacy
Jul 7, 2023 filed
Beneficial ownership filing history
Showing 3 of 4 parsed filing(s) · 1 older require more history access| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| Morgan Stanley CIK0000895421 | May 31, 2026 observed Jun 5, 2026 filed · 5d Schedule 13G amendment | Earliest Schedule 13G amendment found | 9 | 0.00% | |||
| State Street CIK0000093751 | Mar 31, 2026 observed May 12, 2026 filed · 42d Initial Schedule 13G | Initial Schedule 13G | 6.8M | 12.00% | |||
| T. Rowe Price Investment Management CIK0001897612 | Sep 30, 2024 observed Nov 14, 2024 filed · 45d Schedule 13G amendment | Earliest Schedule 13G amendment found | 3.0M | 2.50% |
Explore more institutional activity
Related research
Crawlable links to other securities with similar institutional consensus or recent multi-institution accumulation.